ストックスクリーナーアプリを入手
3.27
2.10%
-0.07
プレマーケット:
3.33
0.06
+1.83%
Fortress Biotech Inc (FBIO) 最新ニュース
Fortress Biotech Inc (FBIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fortress Biotech Inc (FBIO) Balance Sheet - TradingKey
Fortress Biotech Inc (FBIO) Institutional Confidence - TradingKey
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing - The Manila Times
FBIO|Fortress Biotech Inc|Price:3.340|Chg%:-0.090 - TradingKey
Fortress Biotech Inc (FBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fortress Biotech Inc (FBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Fortress Biotech, Inc.9.375% Series A Cumulative Redeemable Perpetual Preferred Stock - TradingView
Fortress Biotech Inc (FBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fortress Biotech Inc (FBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fortress Biotech: Cash Above Market Cap And Royalty Upside Make This A Speculative Buy - Seeking Alpha
Fortress Biotech Preferred Stock (FBIOP) Holds Steady Near Support Amid Low Volume TradingMerger Arbitrage - dars.gov.et
Technical Reactions to FBIOP Trends in Macro Strategies - Stock Traders Daily
$3.74 | Fortress Biotech, Inc. Common Stock (FBIO) Stock Price Today - Binance
Fortress Biotech Achieves 73.6% Return in the Stock Market Over Past Year - MarketsMojo
MSN Money - MSN
CNB0 Bond Coupon Profile — Rate & Payments - TradingView
Crinetics Pharmaceuticals Acquired by Fortress Biotech for $10 Billion - BioBuzz
Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Q1 2026 Earnings: EPS Misses Estimates Significantly, Stock DeclinesEarnings Weakness Phase - dars.gov.et
Fortress Biotech (FBIO) Edges Lower Amid Quiet Trading, Holds Above Key SupportWeekly Profile - DonanımHaber
Fortress Biotech highlights its biotech portfolio strategy as a Nasdaq-listed micro-cap - Ad Hoc News
Mustang Bio (MBIO) Registration Filing Summary - Quartr
Fortress Biotech Preferred Shares (FBIOP) Slide 1.98% as Support Test ApproachesPut Flow Alert - dars.gov.et
Fortress Biotech focuses on specialty pharma growth and licensing model - Ad Hoc News
Crinetics Pharmaceuticals Acquired by Fortress Biotech for $10 B - GuruFocus
Fortress Biotech (FBIO) Slides 2.14% as Selling Pressure Persists Near Support LevelHigh Dividend Factor - dars.gov.et
Fortress Biotech Inc highlights its specialty pharma model as investors assess long-term prospects - Ad-hoc-news.de
Fortress Biotech, Inc. Actuals & Estimates (NASDAQ:FBIO) - TradingView
Trading the Move, Not the Narrative: (FBIOP) Edition - Stock Traders Daily
FBIO Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView
Form 4 Fortress Biotech Inc For: 24 June By Investing.com - Investing.com Nigeria
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Yahoo Finance
Fortress Biotech (NASDAQ: FBIO) CFO receives 400,000 RSU award - Stock Titan
Enterprise value to revenue forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView
FBIOP Q1 2026 Earnings: Significant EPS Miss Highlights Ongoing Challenges for Fortress BiotechAnalyst Coverage Count - dars.gov.et
Fortress Biotech (NASDAQ: FBIO) reports 2026 director and auditor vote tallies - Stock Titan
Fortress Biotech Inc (FBIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fortress Biotech Inc. (FBIO) Q4 2025 Earnings: EPS Misses Estimates on Higher R&D CostsCash Flow Report - dars.gov.et
Fortress Biotech StockSaturday deep dive on the business model - AD HOC NEWS
Fortress Biotech Inc (FBIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mustang Bio Inc (MBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fortress Biotech (FBIO) AGM 2026 Summary - Quartr
Fortress Biotech Inc Annual Shareholders Meeting Transcript - GuruFocus
Fortress Biotech Inc (FBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fortress Biotech Inc. Q4 2025 Earnings: EPS Misses Estimates, Stock Rises Amid Strategic UpdateRevenue Miss Report - dars.gov.et
(FBIOP) Volatility Zones as Tactical Triggers - Stock Traders Daily
FBIOP Q4 2025 Earnings: Preferred Stock Reports Wider-than-Expected Loss Amid Narrowing Pipeline Progress - newsline.com
Fortress Biotech Preferred Stock (FBIOP) Edges Higher Before Resistance TestPut Support - newsline.com
Why Is Fortress Biotech Stock Falling Today? - MSN
FBIOP Q4 2025 Earnings: Preferred Stock Faces EPS Miss as Company Reports LossEPS Revision Trend - newsline.com
Fortress Biotech Preferred Stock (FBIOP) Faces Resistance, Slides 2.3% in Quiet SessionProtective Put - newsline.com
Fortress Biotech Preferred Stock (FBIOP) Pulls Back 2.3% as Shares Approach Key SupportDescending Triangle - newsline.com
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):